Abstract
Macrophage activation syndrome (MAS) is a serious, potentially fatal complication of rheumatic diseases, which is seen most frequently in systemic onset juvenile idiopathic arthritis (soJIA).
Highlights
Macrophage activation syndrome (MAS) is a serious, potentially fatal complication of rheumatic diseases, which is seen most frequently in systemic onset juvenile idiopathic arthritis. This case is reported to expose the difficulties of diagnosis and management of MAS due to soJIA in a patient with liver transplantation
When she was transferred to our clinic, physical examination was notable for temperature ranged from 40° C to above and maculopapular rash
Intravenous methylprednisolone (IV) methylprednisolone was administered at a dose of 30 mg/kg/day for three days and switched to prednisolon 2 mg/kg/day
Summary
Macrophage activation syndrome (MAS) is a serious, potentially fatal complication of rheumatic diseases, which is seen most frequently in systemic onset juvenile idiopathic arthritis (soJIA). Macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis in a case with liver transplantation Introduction Macrophage activation syndrome (MAS) is a serious, potentially fatal complication of rheumatic diseases, which is seen most frequently in systemic onset juvenile idiopathic arthritis (soJIA). Objectives This case is reported to expose the difficulties of diagnosis and management of MAS due to soJIA in a patient with liver transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.